Nathalie Chevalier
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A novel gluconeogenic route enables efficient use of erythritol in zoonotic Brucella.
Journal: Frontiers in veterinary science
Published: October 26, 2023
DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia.
Journal: Molecular genetics and metabolism
Published: September 21, 2023
SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia.
Journal: Cellular and molecular life sciences : CMLS
Published: March 16, 2023
Successful use of empagliflozin to treat neutropenia in two G6PC3-deficient children: Impact of a mutation in SGLT5.
Journal: Journal of inherited metabolic disease
Published: March 24, 2022
Impaired glucose-1,6-biphosphate production due to bi-allelic PGM2L1 mutations is associated with a neurodevelopmental disorder.
Journal: American journal of human genetics
Published: January 28, 2021
Failure to eliminate a phosphorylated glucose analog leads to neutropenia in patients with G6PT and G6PC3 deficiency.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 11, 2019
Metabolite proofreading in carnosine and homocarnosine synthesis: molecular identification of PM20D2 as β-alanyl-lysine dipeptidase.
Journal: The Journal of biological chemistry
Published: June 04, 2014
Ubiquitination of the glycosomal matrix protein receptor PEX5 in Trypanosoma brucei by PEX4 displays novel features.
Journal: Biochimica et biophysica acta
Published: May 17, 2013
Studies on the organization of the docking complex involved in matrix protein import into glycosomes of Trypanosoma brucei.
Journal: Biochemical and biophysical research communications
Published: July 05, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026